PATENT CLAIM ANALYSIS

Application Number: 16107689
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "158000"]

Abstract:
Provided herein (among other things) are protease inhibitor compounds having enhanced features, along with methods for administering such compounds. For example, the subject compounds can be administered without concomitant administration of a CYP3A4 inhibitor, have increased therapeutic index and/or increased potency, and are low-resistance inducing in nature.

Claim (Index 17):
Use of an HIV protease inhibitor conjuage in a method of treating an individual infected with HIV, wherein the HIV protease inhibitor conjugate possesses an increased therapeutic index and/or increased potency relative to the HIV protease inhibitor in unconjugated form.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 96.0
- Lexical Diversity: 1.19565
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15228793', '12530363', '14055581', '13933319', '13411089']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7615166101118812
- 35 USC 102 Novelty (BERT): 0.6419524203888347
- Combined Prediction Score: 0.7495601911395766
- Mean Citation Score: 321.917588
- Max Citation Score: 658.2316
- Similarity Product: 552.064333309865

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test